Vivet Therapeutics will be making a presentation on its lead product
Jean-Philippe Combal, Vivet Therapeutics' CEO, will be attending the 3rd Annual Gene Therapy for Rare Disorders conference in Boston (March 26-28 2019).
Vivet Therapeutics' CEO, Jean-Philippe Combal
Anne Douar, Chief Development Officer of Vivet Therapeutics
Jean-Philippe Combal, Vivet Therapeutics' CEO
Vivet Therapeutics CEO, Jean-Philippe Combal
Jean-Philippe Combal, Vivet Therapeutics' CEO, and Thomas Daniel, BD Director, will be hosting 1x1 meetings during Jefferies 2018 London Healthcare Conference on…
Anne Douar, Chief Development Officer of Vivet Therapeutics
Vivet Therapeutics will be at the upcoming European Society of Gene And Cell Therapy (ESGCT) 26th annual congress in Lausanne…